Targeting the β‐clamp in Helicobacter pylori with FDA‐approved drugs reveals micromolar inhibition by diflunisal
- 26 July 2017
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 591 (15) , 2311-2322
Abstract
The β‐clamp is the processivity‐promoting factor for most of the enzymes in prokaryotic DNA replication; hence, it is a crucial drug target. In the present study, we investigated the β‐clamp from Helicobacter pylori, aiming to seek potential drug molecules against this gastric‐cancer‐causing bacterium. An in silico screening of Food and Drug Administration (FDA) approved drugs against the H. pylori β‐clamp, followed by its in vitro inhibition using a surface competition approach, yielded the drug diflunisal as a positive initial hit. Diflunisal inhibits the growth of H. pylori in the micromolar range. We determined the structure of diflunisal in complex with the β‐clamp to show that the drug binds at subsite I, which is a protein–protein interaction site. Successful identification of FDA‐approved molecules against H. pylori may lead to better and faster drug development.Keywords
Funding Information
- DST-SERB
This publication has 40 references indexed in Scilit:
- The UmuC subunit of the E. coli DNA polymerase V shows a unique interaction with the β-clamp processivity factorBMC Structural Biology, 2013
- Therapeutic target database update 2012: a resource for facilitating target-oriented drug discoveryNucleic Acids Research, 2011
- Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pyloriEast Asian genomesBMC Microbiology, 2011
- REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D Structural Biology, 2011
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D Structural Biology, 2011
- e-LEA3D: a computational-aided drug design web serverNucleic Acids Research, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori InfectionClinical Gastroenterology and Hepatology, 2010
- Coadaptation of Helicobacter pylori and humans: ancient history, modern implicationsJournal of Clinical Investigation, 2009
- [20] Processing of X-ray diffraction data collected in oscillation mode1997